Veterinary pharmaceutical companies Norbrook Laboratories and Merial have launched twin appeals of two IP Australia decisions allowing Bayer to amend a proposed patent for a treatment for mammary gland infections.
Ex-CFO of Octaviar unit charged with $4.6M fraud
Botox alternatives likened to ‘iPhone accessories’ as trade mark trial kicks off
In its opening submissions in a trade mark case brought by Botox maker Allergan, Australian cosmetics brand Self Care compared its used of the word Botox to describe its alternative cosmetic products to the iPhone secondary accessories market, saying its use did not imply an affiliation with the injectable wrinkle treatment’s maker.
Piper Alderman partner rejected offer to leave on a ‘dignified basis’, court told
Key witness in Hastie Services execs’ trial pointed the finger to save herself, jury hears
Novartis appeals IP Australia decision invalidating MS drug patent
Judge denies costs to objector in Willmott Forest MIS class actions
An investor who successfully objected to an initial settlement of four class actions over the failed Willmott Forests managed investment scheme lost a bid to have his legal costs paid by the defendants, with a judge saying the objections were not the primary basis for his refusal to sign off on the agreement.